Literature DB >> 26297250

Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.

Kristine M Cornejo1, Fei Dong2, Amy G Zhou3, Chin-Lee Wu2, Robert H Young2, Kristina Braaten2, Peter M Sadow2, G P Nielsen2, Esther Oliva2.   

Abstract

Histologic prognostic parameters in papillary renal cell carcinoma (PRCC) are unclear. The aims were to review the clinicopathological features of PRCC, including Fuhrman grade and International Society of Urological Pathology (ISUP) nucleolar grade, and to identify parameters that may be independent prognostic indicators. PRCCs in patients treated by nephrectomy were retrieved from the pathology files from 1984 to 2010. Parameters studied included tumor multifocality, size, PRCC type (1 or 2), Fuhrman grade, ISUP nucleolar grade, presence of necrosis, lymphovascular invasion, and stage at presentation. Cancer-specific survival (CSS) and overall survival (OS) were used as prognostic measures. Of 154 PRCCs, 112 (73%) were type 1, and 42 (27%), type 2. A total of 125 patients were male, and 29, female, with ages from 26 to 86 (mean, 62.7) years. Fuhrman grade was 1 in 8 (5%), 2 in 95 (62%), 3 in 49 (32%), and 4 in 2 (1%) tumors, respectively. ISUP nucleolar grade was 1 in 47 (31%), 2 in 56 (36%), 3 in 49 (32%), and 4 in 2 (1%) tumors, respectively. Mean follow-up interval was 73.9 months (0.13-222 months). ISUP nucleolar grade was a significant predictor of both CSS and OS in univariate (CSS, P = .001; OS, P = .004) and multivariate (CSS, P = .04; OS, P = .008) analyses, whereas Fuhrman grade was only predictive of CSS in univariate (P = .001) and multivariate (P = .04) analyses. Only ISUP nucleolar grade and lymphovascular invasion were independently prognostic for CSS and OS in univariate and multivariate analyses. Therefore, the ISUP nucleolar grade appears to be superior in predicting survival in patients with PRCC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fuhrman grade; ISUP; International Society of Urological Pathology nucleolar grade; PRCC; Papillary renal cell carcinoma; Prognosis

Mesh:

Year:  2015        PMID: 26297250     DOI: 10.1016/j.humpath.2015.07.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade.

Authors:  Yu Deng; Erik Soule; Aster Samuel; Sakhi Shah; Enming Cui; Michael Asare-Sawiri; Chandru Sundaram; Chandana Lall; Kumaresan Sandrasegaran
Journal:  Eur Radiol       Date:  2019-05-24       Impact factor: 5.315

2.  Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.

Authors:  Kevin Faust; Adil Roohi; Alberto J Leon; Emeline Leroux; Anglin Dent; Andrew J Evans; Trevor J Pugh; Sangeetha N Kalimuthu; Ugljesa Djuric; Phedias Diamandis
Journal:  JCO Clin Cancer Inform       Date:  2020-09

3.  Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.

Authors:  Levente Kuthi; Alex Jenei; Adrienn Hajdu; István Németh; Zoltán Varga; Zoltán Bajory; László Pajor; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2016-12-28       Impact factor: 3.201

4.  Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection.

Authors:  Motoaki Yasukawa; Noriyoshi Sawabata; Takeshi Kawaguchi; Norikazu Kawai; Tokiko Nakai; Chiho Ohbayashi; Shigeki Taniguchi
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

5.  Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.

Authors:  Nina Wagener; Dominic Edelmann; Axel Benner; Richard Zigeuner; Hendrik Borgmann; Ingmar Wolff; Laura M Krabbe; Mireia Musquera; Paolo Dell'Oglio; Umberto Capitanio; Tobias Klatte; Luca Cindolo; Matthias May; Sabine D Brookman-May
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

Review 6.  Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Lijin Zhang; Zhenlei Zha; Wei Qu; Hu Zhao; Jun Yuan; Yejun Feng; Bin Wu
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

7.  The current status of renal cell carcinoma and prostate carcinoma grading.

Authors:  Brett Delahunt; Lars Egevad; John Yaxley; Hemamali Samaratunga
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

8.  Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas.

Authors:  Manuela Costantini; Maria Luana Poeta; Ruth M Pfeiffer; Dana Hashim; Catherine L Callahan; Steno Sentinelli; Laura Mendoza; Marco Vicari; Vincenzo Pompeo; Angela Cecilia Pesatori; Curt T DellaValle; Giuseppe Simone; Vito Michele Fazio; Michele Gallucci; Maria Teresa Landi
Journal:  Clin Genitourin Cancer       Date:  2021-07-10       Impact factor: 3.121

9.  The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy.

Authors:  Hans Michael Hau; Florian Thalmann; Christoph Lübbert; Mehmet Haluk Morgul; Moritz Schmelzle; Georgi Atanasov; Christian Benzing; Undine Lange; Rudolf Ascherl; Roman Ganzer; Dirk Uhlmann; Hans-Michael Tautenhahn; Georg Wiltberger; Michael Bartels
Journal:  BMC Surg       Date:  2016-07-22       Impact factor: 2.102

10.  Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma.

Authors:  Xiang Le; Xiang-Bo Wang; Hao Zhao; Ren-Fu Chen; Peng Ge
Journal:  BMC Urol       Date:  2020-09-15       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.